Works by Hartmann, Petra


Results: 62
    1
    2
    3
    4
    5
    6
    7

    Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBD<sub>BIO‐ASSIST</sub> study).

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 9, p. 1082, doi. 10.1111/apt.17926
    By:
    • Bokemeyer, Bernd;
    • Plachta‐Danielzik, Sandra;
    • Steiner, Isa Maria;
    • Pohlschneider, Daniela;
    • Urzica, Eugen;
    • Hartmann, Petra;
    • Zemke, Jennifer;
    • Tappe, Ulrich;
    • Schreiber, Stefan;
    • Steinkat, Nadine;
    • Langbrandtner, Jana;
    • Hüppe, Angelika;
    • Stargardt, Tom
    Publication type:
    Article
    8
    9
    10

    Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDO<sub>IBD</sub>‐study

    Published in:
    Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 4, p. 429, doi. 10.1111/apt.17616
    By:
    • Bokemeyer, Bernd;
    • Plachta‐Danielzik, Sandra;
    • di Giuseppe, Romina;
    • Efken, Philipp;
    • Mohl, Wolfgang;
    • Krause, Thomas;
    • Hoffstadt, Martin;
    • Ehehalt, Robert;
    • Trentmann, Leo;
    • Schweitzer, Axel;
    • Jessen, Petra;
    • Hartmann, Petra;
    • Schreiber, Stefan
    Publication type:
    Article
    11
    12

    Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 10, p. 1090, doi. 10.1111/apt.13594
    By:
    • Baumgart, D. C.;
    • Bokemeyer, B.;
    • Drabik, A.;
    • Stallmach, A.;
    • Schreiber, S.;
    • Atreya, Raya;
    • Bachmann, Oliver;
    • Busse, Karin;
    • Bläker, Michael;
    • Börner, Norbert;
    • Büning, Jürgen;
    • Dignass, Axel;
    • Ehehalt, Robert;
    • Ende, Karin;
    • Fischer, Andreas;
    • Jessen, Petra;
    • Hartmann, Franz;
    • Hartmann, Heinz;
    • Hartmann, Petra;
    • Maul, Jochen
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study.

    Published in:
    Journal of Crohn's & Colitis, 2025, v. 19, n. 5, p. 1, doi. 10.1093/ecco-jcc/jjaf052
    By:
    • Bokemeyer, Bernd;
    • Plachta-Danielzik, Sandra;
    • Gilman, Elena;
    • Howaldt, Stefanie;
    • Mohl, Wolfgang;
    • Efken, Philipp;
    • Ehehalt, Robert;
    • Kahl, Matthias;
    • Krause, Thomas;
    • Trentmann, Leo;
    • Lügering, Andreas;
    • Schnoy, Elisabeth;
    • Jochum, Christoph;
    • Hartmann, Petra;
    • Schreiber, Stefan
    Publication type:
    Article
    50

    Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment.

    Published in:
    Journal of Crohn's & Colitis, 2025, v. 19, n. 4, p. 1, doi. 10.1093/ecco-jcc/jjaf051
    By:
    • Bokemeyer, Bernd;
    • Plachta-Danielzik, Sandra;
    • Gilman, Elena;
    • Giuseppe, Romina di;
    • Deppe, Herbert;
    • Mohl, Wolfgang;
    • Teich, Niels;
    • Hoffstadt, Martin;
    • Schweitzer, Axel;
    • von der Ohe, Manfred;
    • Gauss, Annika;
    • Atreya, Raja;
    • Krause, Thomas;
    • Blumenstein, Irina;
    • Hartmann, Petra;
    • Schreiber, Stefan
    Publication type:
    Article